APA

Fujimaki T., Mishima K., Asai A., Tabuchi K., Kobayashi M., Suzuki I. & Kirino T. (20000929). Levels of beta-human chorionic gonadotropin in cerebrospinal fluid of patients with malignant germ cell tumor can be used to detect early recurrence and monitor the response to treatment. : Japanese journal of clinical oncology.

Chicago

Fujimaki T, Mishima K, Asai A, Tabuchi K, Kobayashi M, Suzuki I and Kirino T. 20000929. Levels of beta-human chorionic gonadotropin in cerebrospinal fluid of patients with malignant germ cell tumor can be used to detect early recurrence and monitor the response to treatment. : Japanese journal of clinical oncology.

Harvard

Fujimaki T., Mishima K., Asai A., Tabuchi K., Kobayashi M., Suzuki I. and Kirino T. (20000929). Levels of beta-human chorionic gonadotropin in cerebrospinal fluid of patients with malignant germ cell tumor can be used to detect early recurrence and monitor the response to treatment. : Japanese journal of clinical oncology.

MLA

Fujimaki T, Mishima K, Asai A, Tabuchi K, Kobayashi M, Suzuki I and Kirino T. Levels of beta-human chorionic gonadotropin in cerebrospinal fluid of patients with malignant germ cell tumor can be used to detect early recurrence and monitor the response to treatment. : Japanese journal of clinical oncology. 20000929.